|
Consolidated Statement of Shareholders’ Investment
(dollars in thousands except per share data)
| Year Ended December 31 |
2006 |
2005 |
2004 |
|
 |
Common Shares:
Beginning of Year
Shares: 2006: 1,553,769,958; 2005: 1,575,147,418; 2004: 1,580,247,227 |
$ |
3,477,460 |
|
$ |
3,189,465 |
|
$ |
2,977,718 |
|
 |
Issued under incentive stock programs
Shares: 2006: 14,456,341; 2005: 8,752,085; 2004: 6,811,550 |
|
526,435 |
|
|
299,329 |
|
|
208,880 |
|
 |
Tax benefit from option shares and vesting of
restricted stock awards (no share effect) |
|
42,062 |
|
|
52,363 |
|
|
22,871 |
|
 |
| Share-based compensation |
|
337,428 |
|
|
28,731 |
|
|
28,725 |
|
 |
| Issuance of restricted stock awards |
|
(52,392 |
) |
|
(27,125 |
) |
|
(25,528 |
) |
 |
| Retired — Shares: 2006: 17,635,861; 2005: 30,129,545; 2004: 11,911,359 |
|
(40,064 |
) |
|
(65,303 |
) |
|
(23,201 |
) |
 |
End of Year
Shares: 2006: 1,550,590,438; 2005: 1,553,769,958; 2004: 1,575,147,418 |
$ |
4,290,929 |
|
$ |
3,477,460 |
|
$ |
3,189,465 |
|
 |
Common Shares Held in Treasury:
Beginning of Year
Shares: 2006: 14,534,979; 2005: 15,123,800; 2004: 15,729,296 |
$ |
(212,255 |
) |
$ |
(220,854 |
) |
$ |
(229,696 |
) |
 |
Issued under incentive stock programs
Shares: 2006: 1,197,838; 2005: 588,821; 2004: 605,496 |
|
17,492 |
|
|
8,599 |
|
|
8,842 |
|
 |
Purchased
Shares: 2006: 10,131 |
|
(474 |
) |
|
— |
|
|
— |
|
 |
End of Year
Shares: 2006: 13,347,272; 2005: 14,534,979; 2004: 15,123,800 |
$ |
(195,237 |
) |
$ |
(212,255 |
) |
$ |
(220,854 |
) |
 |
Earnings Employed in the Business:
Beginning of Year |
$ |
10,404,568 |
|
$ |
10,033,440 |
|
$ |
9,691,484 |
|
 |
| Net earnings |
|
1,716,755 |
|
|
3,372,065 |
|
|
3,235,851 |
|
 |
Cash dividends declared on common shares
(per share — 2006: $1.18; 2005: $1.10; 2004: $1.04) |
|
(1,807,829 |
) |
|
(1,704,077 |
) |
|
(1,622,148 |
) |
 |
| Spin-off of Hospira, Inc. |
|
— |
|
|
— |
|
|
(761,916 |
) |
 |
| Cost of common shares retired in excess of stated capital amount |
|
(780,152 |
) |
|
(1,315,397 |
) |
|
(527,197 |
) |
 |
| Cost of treasury shares issued below market value |
|
35,386 |
|
|
18,537 |
|
|
17,366 |
|
 |
| End of Year |
$ |
9,568,728 |
|
$ |
10,404,568 |
|
$ |
10,033,440 |
|
 |
Accumulated Other Comprehensive Income (Loss):
Beginning of Year |
$ |
745,498 |
|
$ |
1,323,732 |
|
$ |
632,752 |
|
 |
| Other comprehensive (loss) income and spin-off of Hospira, Inc. |
|
898,266 |
|
|
(578,234 |
) |
|
690,980 |
|
 |
| End of Year, before adoption of new accounting standard |
|
1,643,764 |
|
|
745,498 |
|
|
1,323,732 |
|
 |
Adjustment to recognize net actuarial gain (loss)
and prior service cost as a component of accumulated
other comprehensive income (loss), net of tax |
|
(1,253,998 |
) |
|
— |
|
|
— |
|
 |
| End of Year |
$ |
389,766 |
|
$ |
745,498 |
|
$ |
1,323,732 |
|
 |
Comprehensive Income |
$ |
2,615,021 |
|
$ |
2,793,831 |
|
$ |
3,906,932 |
|
 |
The accompanying notes to consolidated financial statements are an integral part of this statement. |
|